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1 Introduction 
1.1 Overview 
Covering approximately 2/3 of all dementia cases, Alzheimer’s disease (AD) represents 
the most common form of dementia. Usually affecting people of the age range of 65 and 
above, it is significantly higher spread in individuals of the female gender.1 There are 
approx. 1.2 million people in Germany alone, suffering from the fatal symptoms of this 
neurodegenerative disease.2,3 The symptoms start with short-term memory loss, later 
leading to a complete impairment of cognition and language due to damaged neurons and 
tissue degeneration in parts of the brain realizing cognitive functions such as the cortex 
and hippocampus. Caused by these severe changes in the brain, patients often show 
behavioural impairments, mood swings and changes in personality.4 
The neuropathology of AD was thought to be primarily characterized by the extracellular 
generation and deposition of amyloid-β (A-β) peptides in the brain, first forming 
oligomers which then accumulate to A-β plaques. However, more recent evidence 
indicates that A-β can accumulate intracellularly in neurons, too.5 Toxic versions of A-β 
peptides are generated through abnormal processing of human amyloid precursor protein 
(hAPP). Initiating in the entorhinal cortex and hippocampus, the pathology then spreads 
across other parts of the central nervous system (CNS) causing the death of neurons and 
leading to shrinkage of the brain. To this day, the pharmaceutical market can only offer 
drugs which reduce some of the symptoms of AD. An effective cure, targeting the 
underlying molecular mechanisms of AD has yet to be found. For this reason, researchers 
study the effects of AD in the brain with the help of model organisms, especially 
                                                 
1 Juan Yang et al.: “Induced pluripotent stem cells in Alzheimer's disease: applications for disease 
modeling and cell-replacement therapy” 
2 Alzheimer Forschung Initiative e.V.: “Zahlen und Fakten der Alzheimer-Krankheit in Deutschland” 
3 Statista - Universität Leipzig: “Statistiken zur weltweiten Verbreitung von Demenz” 
4 Juan Yang et al.: “Induced pluripotent stem cells in Alzheimer's disease: applications for disease 
modeling and cell-replacement therapy” 
5 Minho Moon et al.: “Intracellular amyloid-β accumulation in calcium-binding protein-deficient neurons 
leads to amyloid-β plaque formation in animal model of Alzheimer's disease” 
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transgenic rodents.6 The transgenic mice and rats are genetically modified to overexpress 
abnormal versions of hAPP to develop common neuropathology traits of AD.7 Not 
genetically modified mice and rats naturally contain endogenous murine APP, but show 
an absence of toxic amyloid-β deposits which affects the formation of secondary 
structures, such as oligomers. Caused by the differences in neuropathologic traits, the 
typical symptoms and impacts on brain functions, such as memory and behaviour, can’t 
be observed in mouse models.8 
Although there are differences in the amino acid sequence between hAPP and murine 
APP, antibodies available on the market can’t differentiate between these two proteins, 
making it impossible to study and prove the expression patterns of hAPP in mice.9 
Corinna Höfling and colleagues have therefore developed and characterized two 
monoclonal antibodies 1D1 and 7H6 that recognize only human APP by immunological 
methods, such as immunohistochemistry and Western Blot, but also in in vivo 
applications. With the help of the newly developed antibodies, hAPP-expressing 
interneurons in the hippocampus can be studied, which have been found to play a rather 
important role in AD.10,11 
 
1.2 The human brain 
Protected from the skull lies the brain, the part of the body responsible for emotions, 
memories and thoughts. Weighing about 1.0 to 1.5 kg, it contains about 100 billion nerve 
cells and consists of three main sections: the cerebrum, cerebellum, and brain stem.12 
                                                 
6 Corinna Höfling et al.: “Differential transgene expression patterns in Alzheimer mouse models revealed 
by novel human amyloid precursor protein-specific antibodies” 
7 U.S. National Library Of Medicine: “PSEN1 gene” 
8 Corinna Höfling et al.: “Differential transgene expression patterns in Alzheimer mouse models revealed 
by novel human amyloid precursor protein-specific antibodies” 
9 Ibid. 
10 Ibid. 
11 Rice University: “Hippocampus” 
12 Mayfield Clinic: “Anatomy of the Human Brain” 
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As illustrated in figure 1, the cerebrum is the largest part of the brain, containing about 
70% of all nerve cells. It can be divided into the right and left hemisphere, each 
controlling different functions that are crucial in our everyday lives. The dominant, left 
hemisphere primarily controls language and speech while the right hemisphere is 
assigned to spatial processing and interprets visual information transmitted from our eyes. 
Those hemispheres are joined by a bundle of fibres called corpus callosum, allowing them 
to exchange information. The left and right hemisphere again are divided into four lobes: 
the frontal, parietal, occipital and temporal lobe. Connected with each other, they function 
jointly.13 
 
Figure 1: The main sections of the brain: the cerebrum, cerebellum and brain stem. Source: 
http://www.nova.org.au/sites/default/files/images/people-and-medicine/brain/brain-illustrations-02-
v6_670x449.png. Status: 28.04.2017. 
 
The folded tissue top of the cerebrum called the cortex or neocortex allows more neurons 
to exist due to the increased surface. It contains about 70% of all nerve cells in our brain. 
Underneath the cerebrum lies the cerebellum, functioning as a coordinator of muscle 
movements, posture and balance. Connecting the cerebellum and cerebrum to the spinal 
cord, the brain stem performs automatic functions such as breathing and controlling the 
heart rate and body temperature. It can be divided into the midbrain, pons and medulla. 
                                                 
13 Ibid. 
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The cerebellum, pons and medulla form a structure called the hindbrain. Located deep in 
the brain lie other essential structures that are mostly responsible for automatic functions, 
such as the limbic system. It is composed of the hypothalamus, thalamus, amygdala, 
hippocampus, and pituitary gland, as seen in figure 2.14 
 
Figure 2: The components of the limbic system, shown with the cerebral cortex and corpus callosum. The 
corpus callosum is the largest bundle of nerve fibres, containing over 200 million axons. Its function is to 
connect the brain’s cerebral hemispheres.15. Source: 
http://classconnection.s3.amazonaws.com/252/flashcards/1048252/png/forebrain1328987872235.png. 
Status: 28.04.17. 
 
Learning and memory formation are very important processes in the central nervous 
system. They lead to a ‘rewiring’ of the network, through structural reconfiguration of 
synapses induced by activity-change of certain neurons. This rewiring in form of 
establishment and elimination of synapses is a process necessary for the brain to adapt to 
new environments. 16 Different areas of our brain are involved in storing information in 
form of memories. When a person achieves a new skill, it is stored as an automatic 
                                                 
14 Ibid. 
15 David Hubel: “Eye, Brain, and Vision” 
16 Lena C. Schmid et al.: “Dysfunction of Somatostatin-Positive Interneurons Associated with Memory 
Deficits in an Alzheimer’s Disease Model” 
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memory in the cerebellum. Short-term memories are saved in the prefrontal cortex for 
about a minute. Long-term memories on the other hand can be kept for a longer time, 
since it has an almost unlimited content and duration capacity in the hippocampus.17 
Additionally, the hippocampus controls spatial navigation and is therefore the part of the 
brain where AD -symptoms, which include memory problems and disorientation, start to 
appear. Due to the organized anatomic structure in the hippocampus, it is used as a model 
system for neurophysiology studies.18  
1.3 The rodent brain 
 
The brain of a rodent differs most prominently in its structure, which doesn’t appear as 
complex as the human one. When comparing both brain structures, one can also notice a 
prominent area in the rodent brain, which is less distinguished in humans: the olfactory 
bulb. Rodents, as many other mammalians, rely on their olfactory sensibility for viability. 
With the help of this organ, they can distinguish toxic from ‘neutral’ food, but it also 
influences sensing of predators and possible mating partners. Even though the olfactory 
bulb represents one of the most essential and basic parts of the brain, it appears to be very 
complex. To describe the ends of the rodent brain, the anatomical terms ’rostral’ and 
‘caudal’ are used; the olfactory bulb is therefore on the rostral side and the hindbrain on 
the caudal (illustrated in figure 3). 19 Sectioned tissue slices from the caudal and rostral 
side of the rodent brain differ most obviously in the hippocampus area, which is much 
larger on the caudal side (as seen in figure 3). 
 
                                                 
17 Mayfield Clinic: “Anatomy of the Human Brain” 
18 Rice University: “Hippocampus” 
19 Christof Koch and R. Clay Reid: “Neuroscience: Observatories of the mind” 
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Figure 3: Comparison of the human and mouse brain in a lateral and sectioned view (left). Right picture 
depicts the whole lateral brain and sectioned brain tissue. The rostral area is on the side of the olfactory 
bulb, whereas the hindbrain side represents the caudal area.20 A) Rostral brain area. B) Caudal brain 
area.21 Source: http://www.getdomainvids.com/rdg.html? Status: 15.08.2017. 
 
Because the rodent brain anatomy is so different, especially in the parts associated with 
higher cognitive function, neurological disorders such as Alzheimer’s disease do not trail 
the exact same pathological paths as in the human brain. For this reason, animal models 
will probably ever be able to mimic the aspects and traits of a human neurological disease 
to only a certain extent, solely by the fact that their mentality is not comparable to ours. 
 
1.4 Interneurons 
As seen in figure 4, the hippocampus of rodents and humans is a bilaminar structure 
consisting of the dentate gyrus (DG) and cornu ammonis (CA) which is also called the 
hippocampus proper. 
                                                 
20 Joanne Mayer, Michelle G. Hamel and Paul E. Gottschall: “Evidence for proteolytic cleavage of brevican 
by the ADAMTSs in the dentate gyrus after excitotoxic lesion of the mouse entorhinal cortex” 
21 Ibid. 
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Figure 4: The layers of the hippocampus in mice: Alveus, stratum oriens, stratum pyramidale, stratum 
radiatum, stratum lacunosum moleculare and the dentate gyrus. Original picture: 
http://anatomie.vetmed.uni-leipzig.de/external/hippocampus/index.html. Status: 28.04.17. 
 
Both structures are separated into multiple layers that can be differentiated under the 
microscope. The CA consists of four fields CA1 to CA4, which are necessary to describe 
the cell layers in different positions of the cornu ammonis. One of the most prominent 
layers is the stratum pyramidale. The pyramidal cells in this layer represent the cornu 
ammonis’ principal cells, which are major sources of output to the rest of the brain like 
all other principal cells. The name of these cells derives from the triangular soma, which 
allows for a quick and certain identification. 22 
Together with the stratum lacunosum and the stratum moleculare in the dentate gyrus, 
these layers contain the highest number of so called interneurons in the hippocampus.23 
Interneurons, owning diverse morphological, physiological, molecular and synaptic 
characteristics, make up about 25% of cortical neurons. 24 Their neuron type is neither 
                                                 
22 Henri M. Duvernoy, Françoise Cattin and Pierre-Yves Risold: "The Human Hippocampus" 
23 Ibid. 
24 Learn.Genetics: “The Other Brain Cells” 
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sensory, motoric nor projecting, but specialized with their primary role being the 
formation of connections between other types of neurons with the help of witch they 
transfer impulses throughout the CNS. These cells are mostly inhibitory, using -
aminobutyric acid (GABA) as a neurotransmitter and are vital in the wiring and circuitry 
of developing nervous systems.25 Released by electrically-stimulated inhibitory neurons, 
GABA turns the membrane potential more negative, hindering the neuron in reaching a 
threshold large enough to fire an action potential.26,27 GABA and glutamate (a 
neurotransmitter of excitatory neurons) represent 90% of all neurotransmitters in the 
brain, hence a balance between the two is essential for a properly functioning CNS. Both 
neurotransmitters originate from glutamine, which, in glutamatergic neurons, is converted 
into glutamate through catalysis by phosphate-activated glutamine synthetase and 
glutaminase. In GABAergic, inhibitory neurons glutamate is further altered by 
decarboxylation catalysed with glutamate decarboxylase into GABA, as depicted in 
figure 5.28 As GABA’s main function, it opens ion channels that are permeable for 
chloride, bicarbonate or potassium ions in postsynaptic (occurring distal to a synapse) 
neurons, through inhibitory postsynaptic potential.29,30 Chloride-channelling has the 
benefit of stabilizing the membrane potential to reach a negative near resting level, 
allowing the ion channels to recover.31  
                                                 
25 Corey Kelsom and Wange Lu: “Development and specification of GABAergic cortical interneurons” 
26 Knowing Neurons: “Inhibitory Neurons: Keeping the Brain’s Traffic in Check” 
27 RICHARD W. OLSEN: “GABA” 
28 Joanna M et al.: “The Loss of Glutamate-GABA Harmony in Anxiety Disorders” 
29 Learn.Genetics: “The Other Brain Cells” 
30 RICHARD W. OLSEN: “GABA” 
31 PhysiologyWeb Team: “Physiological Significance of the Membrane Potential” 
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Figure 5: In GABAergic and glutamatergic neurons glutamine is converted into glutamate through 
catalysis by phosphate-activated glutamine synthetase and glutaminase, whereas in GABAergic neurons 
glutamate is further converted into GABA by decarboxylation catalysed with glutamate decarboxylase.32 
Original picture: https://oatext.com/img/Glutamate-transporters-1.jpg; edited by Emira Shehabi. Status: 
28.04.2017. 
 
The structure of a typical interneuron is illustrated in figure 6 and can be compared to the 
structure of a sensory neuron, showing the cell body with the nucleus at the centre and 
the dendrites, axon and synaptic endings with which the interneuron connects to other 
neurons in the brain. Sensory, motor and interneurons have similar structures, but differ 
in function. While interneurons connect neurons, sensory neurons gather information 
from sensory organs and motor neurons carry impulses from the brain and the spinal cord 
to muscles.33 
                                                 
32 Joanna M et al.: “The Loss of Glutamate-GABA Harmony in Anxiety Disorders” 
33 Scientific American Blog Network: “Know Your Neurons: How to Classify Different Types of Neurons in 
the Brain's Forest” 
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Figure 6: The structure of an interneuron (left) and of a sensory neuron (right). Source: 
http://www.biologymad.com/nervoussystem/relayneurone.jpg (left); http://classtalkers.com/wp-
content/uploads/2011/11/structure_of_a_neurone1.jpg (right). Status: 24.08.2017. 
 
The functions of interneurons are still not completely understood, but studies show that 
they could play a vital role in modulating cortical output and plasticity and that they are 
possibly specialized to target different parts of neurons, because of their excitatory and 
inhibitory characteristics. Regarding AD, researchers have found the characterization of 
interneuron types and their location to be very important for research that focuses on 
developing new drug therapies against the disease. The study described interneurons as 
rather vulnerable to AD -related damage, since certain interneurons express abnormally 
high levels of APP which leads to the formation of neurotoxic A-β oligomers and amyloid 
plaques. A small number of damaged interneurons can already cause memory and 
learning impairments, accelerating the course of the disease. 34 
Interneurons typically express many neuropeptides and calcium-binding proteins 
(CaBPs) such as calmodulin (CM), calretinin (CR), calbindin (CB) and parvalbumin 
                                                 
34 Heather Caroline Rice: “Selective Vulnerability of Interneurons in Alzheimer’s Disease” 
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(PV). These proteins can be used to mark pathways and cells with the help of specific 
antibodies that detect them. CM is the most distributed CaBP. It affects several Ca2+-
dependent regulations of enzymes and cell processes by binding Ca2+ to all four of its 
binding sites. CB protects neurons from being flooded with calcium-ions, which can 
occur, when damaged neurons spill out glutamate into neighbouring areas and cause cell 
death. 35 It has been reported to occur in 10-20% of GABAergic interneurons in the 
hippocampus.36 One of the least abundant CaBPs is CR, due to only 13% of GABAergic 
interneurons in the mouse being CR -positive.37 Functioning as a regulator of other 
GABAergic inhibitory interneurons, it additionally regulates the excitatory action of 
principal cells. Neuroscientific research has discovered a selective vulnerability of CR-
positive interneurons to neurodegeneration induced by A-β deposits. But only severe AD 
-cases have shown a significantly reduced density of CR -positive interneurons in the 
hippocampus. 38 PV has a similar function and structure to CM. Because of its usual 
colocalization with GABA, it is used as a marker for subpopulations of GABAergic 
neurons. 39 Around 32-38% of GABAergic interneurons in the hippocampus of the mouse 
are PV -positive.40 Named basket cells due to their widely reaching dendrites, these cells 
can fire action potentials at a high rate while concurrently having short recovery times.41 
Experiments in an AD -model have shown that restoration of PV -positive inhibitory 
neurons led to better performance in memory tasks. PV -positive interneurons can 
therefore be regarded as actively involved in learning and memory formation.42 These 
CaBPs occur in certain subpopulations of neurons in the brain, such as in the interneurons 
                                                 
35 Andressen C. et al: “Calcium-binding proteins: selective markers of nerve cells.” 
36 Dhiraj Maskey et al.: “Changes in the distribution of calbindin D28-k, parvalbumin, and calretinin in the 
hippocampus of the circling mouse” 
37 Ibid. 
38 David Baglietto-Vargas et al.: “Calretinin interneurons are early targets of extracellular amyloid-beta 
pathology in PS1/AbetaPP Alzheimer mice hippocampus” 
39 Andressen C. et al.: “Calcium-binding proteins: selective markers of nerve cells.” 
40 Dhiraj Maskey et al.: “Changes in the distribution of calbindin D28-k, parvalbumin, and calretinin in the 
hippocampus of the circling mouse” 
41 Knowing Neurons: “Inhibitory Neurons: Keeping the Brain’s Traffic in Check” 
42 Lena C. Schmid et al.: “Dysfunction of Somatostatin-Positive Interneurons Associated with Memory 
Deficits in an Alzheimer’s Disease Model”  
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of the hippocampal area. Utilizing antibodies against CaBPs in immunohistochemical 
methods, targeted areas in the brain can be marked where these proteins reside.43  
An interneuronally expressed neuropeptide is e.g. somatostatin (SST). It is also produced 
in other neurons and secretory cells in the central and peripheral nervous system and 
gastrointestinal tract and released by membrane depolarization or increasing Ca2+ -
concentration in the cell. Its function is to inhibit secretion of neurotransmitters or 
hormones. Many hormones, neuropeptides, neurotransmitters, nutrients and other 
compounds stimulate SST -secretion, while opiates and GABA usually play an inhibiting 
role.44 Studies have shown the importance of SST in AD, stating that a single nucleotide 
polymorphism in the SST -gene can already increase AD -risk. 45  
 
1.4.1 Morphology of interneurons 
Inhibitory interneurons show big differences in somatic, dendritic and axonal 
morphologies, but vary the most in their dendritic morphology, by which they cannot be 
reliably defined. Only the axonal morphology can securely identify the interneuron type, 
due to the fact that interneurons seem to target different domains of neurons. Interneurons 
can be subdivided into basket, double bouquet, bipolar, bitufted, martinotti and chandelier 
cells, as shown in figure 7. 
 
                                                 
43 Andressen C. et al: “Calcium-binding proteins: selective markers of nerve cells.” 
44 Noemí Bronstein-Sitton: “Somatostatin and the Somatostatin Receptors” 
45 Yadong Huang and Lennart Mucke: “Alzheimer mechanisms and therapeutic strategies” 
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Figure 7: Different morphologic appearances of interneurons. (A) Horizontal neuron. (B) Bitufted 
neuron. (C) Chandelier neuron. (D) Basket neuron. (E) Aspiny stellate cell. (F) Pyramidal neuron. (G) 
Martinotti cell. Source:46; edited by: Emira Shehabi. Status: 31.07.2017. 
 
Approximately 50% of inhibitory neurons are of the basket cell type. They target the 
somata and proximal dendrites of pyramidal neurons and interneurons. Because of 
innervation by many basket cells, they exhibit a basket-like appearance around pyramidal 
cell somata. They can be subdivided into large, small and nest basket cells, expressing 
many neuropeptides and the CaBPs PV and CB. Large basket cells have larger dendrites 
than the other two basket cell types and expansive axonal arborizations. They typically 
express CB, PV and occasionally SST and CR. Chandelier cells target axons and are 
named after their chandelier-like appearance, which seems to take clearer forms in higher 
specimens, such as primates. They express parvalbumin, calbindin or even both CaBPs. 
Martinotti cells target proximate and distal dendrites and somata. They appear bitufted 
with a more elaborate dendritic tree than other interneurons and typically express the 
neuropeptide SST. Bipolar cells are small with spindle or ovoid somata and express CR, 
while double bouquet cells appear with a bitufted dendritic morphology and express CB, 
CR or both together. Bitufted cells, on the other hand, are characterized by their ovoid 
somata and wide horizontal axonal spans. Targeting dendrites, they express CB, CR and 
SST. 47 
 
                                                 
46 C. Pesold et al.: “Cortical bitufted, horizontal, and Martinotti cells preferentially express and secrete 
reelin into perineuronal nets, nonsynaptically modulating gene expression” 
47 Henry Markram et al.: “Interneurons of the neocortical inhibitory system” 
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1.4.2 Colocalization 
Neuropeptides and CaBPs can colocalize with other compounds or with each other in 
neurons and interneurons. The term colocalization, as a biological designation, describes 
two or more different compounds that are located in the same spot in an organism. When 
used in the context of tissue, colocalization of two molecules could mean joint sharing of 
the same receptor. In the context of fluorescent microscopy, it refers to fluorescent 
molecules, whose colours share the same pixel in the image. By means of double 
immunofluorescent staining, two or more different, fluorescently-labelled molecules can 
be marked and the possibility of colocalization investigated with a fluorescent microscope 
through overlay of fluorescent filters. Examining possible physical co-occurrence of 
compounds is very important for the analysis of biological interactions. 48  
Interneurons have the ability to co-express up to five different neuropeptides and CaBPs. 
Many of those molecules appear to be expressed independently of each other like CB, 
which can be seen colocalizing with many neuropeptides and other CaBPs. Regarding 
CaBPs, calbindin, calretinin and parvalbumin are primarily expressed separately in 
different populations of interneurons. In some cases, expressions of some of those CaBPs 
overlap and result in colocalizing compounds. Calbindin and parvalbumin occasionally 
are found to co-occur, while the combination of calbindin and calretinin is rarer.49 
The three CaBPs occur mostly in three broad interneuron classes: PV in fast-spiking, CB 
in bursting and CR in accommodating or irregular-spiking interneurons. But because 
more than three anatomical, electrical and combined types exist, these proteins can’t be 
assigned to only one interneuron class and therefore colocalization occurs.50 
 
1.5 Pathology of Alzheimer’s disease and its animal models 
Amyloid-β peptides occur naturally through cleavage of APP by - and γ-secretase. 
BACE1 or -secretase is essential for the cleavage of APP, because it initiates A-β -
                                                 
48 Bywalez and Wolfgang: “Physiology of rodent olfactory bulb interneurons” 
49 Henry Markram et al.: “Interneurons of the neocortical inhibitory system” 
50 Ibid. 
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formation by producing the N-terminus of A-β. 51 Cleaving APP at its -site, the enzyme 
generates the C-terminal fragment C99, which is membrane bound and subsequently 
processed by γ-secretase to release A-β. Due to the enzyme’s necessity in the initiation of 
A-β -cleavage, it is a prime drug target for AD. 52 The γ-secretase cleaves transmembrane 
proteins in the brain thereby forming peptides, such as soluble APP (sAPP), a compound 
that can be neuroprotective and stimulate neurogenesis. The proteolytic function of this 
complex is assigned to the protein-subunit presenilin 1, which is encoded by the PSEN1 
gene. According to studies, 70% of early-onset AD cases have mutations in their PSEN1 
gene. More than 150 mutations of the PSEN1 gene, most of them point mutations, have 
been identified in these patients. The mutated gene produces abnormal presenilin 1 
proteins, altering the function of γ-secretase, changing the processing of APP and causing 
an overproduction of longer, toxic versions of A-β peptides that form plaques in the 
hippocampus.53 Formerly, extracellular formation of A-β has been assumed to be crucial 
for the formation of plaques in the brain. Recent research has shown evidence that A-β 
can also accumulate inside of neurons, which is even supposed to accelerate AD -
progression. Here, intraneuronal A-β (iA-β) is accumulated and leads to the degeneration 
of the neuron, which secretes iA-β into the extracellular space, where it forms plaques. 
This evidence has been gathered in AD -patients and some transgenic animals, but it has 
not been investigated in transgenic AD -mouse models yet.54 
Neurons exposed to high levels of toxic A-β peptides usually shrink, developing shorter 
dendrites with less dense spines. Increased turnover of dendrite spines has been observed 
in inhibitory neurons, lessening the amount of input that the neuron can achieve. The 
shrinkage can increase cellular excitability and thus production of glutamate, creating an 
imbalance between excitation and inhibition which could be the basis for neuronal 
                                                 
51 Patty C. Kandalepas and Robert Vassar: “The Normal and Pathologic Roles of the Alzheimer's β-
secretase, BACE1” 
52 Robert Vassar et al.: “The beta-secretase enzyme BACE in health and Alzheimer's disease: regulation, 
cell biology, function, and therapeutic potential” 
53 U.S. National Library Of Medicine: “PSEN1 gene” 
54 Minho Moon et al.: “Intracellular amyloid-β accumulation in calcium-binding protein-deficient neurons 
leads to amyloid-β plaque formation in animal model of Alzheimer's disease” 
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network dysfunction.55,56 Additionally, toxic A-β peptides have been shown to decrease 
the number of synapses in the brain and inhibit proper structural remodelling of excitatory 
synapses and dendrites, which can explain AD -typical impairments in memory.57  
 
To find therapeutic strategies that can reduce toxic A–β generation, transgenic mice have 
been developed that are used as AD -model organisms. These mice overexpress abnormal 
human APP (hAPP) and presenilin 1 proteins and thus develop many AD –features, such 
as A–β deposition and plaques, signs of neurodegeneration and memory impairment. One 
of the most used transgenic mouse models is the Tg2576 mouse. This transgenic mouse 
species overexpresses the hAPP -isoform with 695 amino acids and develops A–β plaques 
in the age of 9–10 months.58 Due to simultaneous murine APP -production, the models 
show a difference in spatial and temporal appearance of toxic A–β deposits and synaptic 
dysfunction as well as discrepancies in impairments in memory and behaviour, resulting 
from the differences between murine and human APP.59 Unfortunately, a full replication 
of the human disease is not possible due to absence of neurofibrillary tangles and little to 
no neuronal loss in the brains of experimental animals.60 
 
1.6 Goal 
The goal of this thesis was the detection and characterization of different types of hAPP 
-expressing interneurons in the hippocampus of transgenic mice. To achieve this goal the 
hAPP -specific antibody 1D1 was used in immunohistochemical methods. Emphasis was 
                                                 
55 Jorge J. Palop and Lennart Mucke: “Network abnormalities and interneuron dysfunction in Alzheimer 
disease” 
56 Lena C. Schmid et al.: “Dysfunction of Somatostatin-Positive Interneurons Associated with Memory 
Deficits in an Alzheimer’s Disease Model” 
57 Ibid. 
58 Anniina Snellman et al.: “Longitudinal amyloid imaging in mouse brain with 11C-PIB: comparison of 
APP23, Tg2576, and APPswe-PS1dE9 mouse models of Alzheimer disease” 
59 Corinna Höfling et al.: “Differential transgene expression patterns in Alzheimer mouse models revealed 
by novel human amyloid precursor protein-specific antibodies” 
60 Anniina Snellman et al.: “Longitudinal amyloid imaging in mouse brain with 11C-PIB: comparison of 
APP23, Tg2576, and APPswe-PS1dE9 mouse models of Alzheimer disease” 
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given on the determination of the number of interneurons in hippocampal layers and their 
exact localization. Additionally, the calcium-binding proteins parvalbumin, calretinin and 
calbindin and the neuropeptide somatostatin were detected using the same methods to 
examine a possible colocalization of these proteins with hAPP in interneurons.  
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2 Material and equipment 
2.1 Material 
2.1.1 Buffers 
 
Buffer Ingredients/ Producer 
 
Phosphate-buffered saline (PBS, 0,1 M, pH 7,4) 
 
 
Na2HPO4: Roth 
NaH2PO4: Roth 
 
PBS/ 0,025% Sodium azide (NaN3) 
 
 
Sodium azide (NaN3): Sigma-
Aldrich 
 
Tris-buffered saline (TBS, 0,1 M, pH 7,4) 
 
 
NaCl: Roth 
Tris: Roth 
 
Tris Buffer (0,05 M, pH 7,6) 
 
 
Tris: Roth 
2.1.2 Other chemicals 
 
Chemicals Producer 
 
Hydrogen peroxide (H2O2, 30%) 
 
 
Merck Millipore 
 
Triton X-100 
 
 
FERAK 
 
 
Methanol 
 
 
 
J.T. Baker 
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Entellan® 
 
 
Sigma-Aldrich 
 
Toluene 
 
 
Roth 
 
 
Protein glycerol 
 
 
Roth 
 
2.1.3 Sera 
 
Serum Producer 
 
Goat-normal serum 
 
 
Dianova 
 
Donkey-normal serum 
 
 
Dianova 
 
Bovine serum albumin (BSA) 
 
 
SERVA 
 
2.1.4 Primary antibodies 
 
Antibody Producer 
 
Rat anti-human APP (clone 1D1 from 
supernatant of rat hybridoma cells) 
 
 
Dr. Kuhn, TU Munich 
 
Rabbit anti-parvalbumin 
 
 
Swant 
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Rabbit anti-calbindin 
 
 
Swant 
 
Rabbit anti-calretinin 
 
Swant 
 
 
Goat anti-somatostatin 
 
Swant 
 
 
2.1.5 Secondary antibodies 
 
Antibody Producer 
 
Donkey anti-rabbit (Cy2-conjugated) 
 
 
Dianova 
 
Donkey anti-goat (Cy2-conjugated) 
 
 
Dianova 
 
Donkey anti-rat (Cy3-conjugated) 
 
Dianova 
 
 
2.2 Preparation of buffers 
Buffer Ingredients and preparation 
 
PBS (0,1 M, pH 7,4) 
 
Solution A (0,2 M) 
 
Na2HPO4 * 2 H2O                                                        35,61 g  
 
Filled up with distilled water to 1 litre. 
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Solution B: 0,2 M 
 
NaH2PO4 * H2O                                                             27,6 g 
 
Filled up with distilled water to 1 litre. 
 
Preparation for solution of pH 7,4 (25°C): 
 
Solution A                                                                       40,5 g 
Solution B                                                                         9,5 g  
 
Mixed and diluted to 100 ml with distilled water. 
 
 
TBS (0,1 M, pH 7,4) 
 
Tris                                                                                  12,1 g 
NaCl                                                                                  8,8 g 
 
Filled up with distilled water to 1 litre. 
 
2.3 Equipment 
 
Equipment and specific identifier Producer 
 
Vortex shakers:  
 
Vortex-Genie 2 
 
 
 
 
Scientific Industries 
 
 
Scales:  
 
Mettler AM50 
 
Mettler Toledo 
 
 
 
Mettler 
 
Mettler 
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Centrifuges: 
 
1-14 
 
 
 
 
Sigma 
 
Optical microscopes: 
 
Stemi DV4 
 
Axioplan 2 
 
Fluorescence microscopes: 
 
BIOREVO BZ-9000 
  
 
 
 
 
Zeiss 
 
Zeiss 
 
 
 
Keyence 
 
Heat plates: 
 
RCTbasic 
 
 
 
 
 
KIKA Labortechnik 
Platform shaker: 
Duomax 1030 
 
Heidolph 
 
 
Thermoshaker: 
 
HC24N 
 
 
 
Grant-bio 
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3 Methods 
In order to examine the hippocampal interneurons of hAPP -transgenic mice, animals 
were sacrificed by CO2 inhalation and perfused with PBS followed by 4% 
paraformaldehyde. The brains were prepared and the cerebrum was separated from the 
cerebellum and cut into 30 µm thin slices at about -40°C. The cut slices were immersed 
in wells filled with PBS and 0,025% NaNO3.  
 
In all following methods, the collected brain slices were washed in a microtiter plate filled 
with 0,1 M Tris-buffered saline (TBS, pH 7,4) 3 times for 5 minutes each time after every 
incubation step (unless stated otherwise). The plate was then placed on a platform shaker. 
For every method, a certain number of brain tissue sections was used. The tissue was 
taken from hAPP -transgenic Tg2576 mice. Preferred were freshly cut brain sections from 
3-month-old mice, because older mice display more background signal with a compound 
called lipofuscin, which is an ‘aging pigment’ that occurs after damaged blood cells have 
been broken down and absorbed.61 The autofluorescence of these pigments in samples of 
aged animals complicates the analysis of stained interneurons. Furthermore, tissue from 
the caudal brain area was decided to be used, because of its large hippocampal area that 
exhibits a higher number of interneurons. 
 
Table 1 contains every primary and secondary antibody that has been utilized in the 
methods except for rat anti-human APP (1D1) in the double immunofluorescence stains 
(DIFS), which was used in every stain in a dilution of 1:2. Targeting rat anti-human APP, 
the secondary antibody, Cy3 -conjugated donkey anti-rat was used. 
The dilutions stated in table 1 have been suggested by the provider. Some dilutions have 
been changed during the experiments in this project, because of too weak/ intense 
background and interneuron staining results.  
 
                                                 
61 MedlinePlus Medical Encyclopedia: “Lipofuscin” 
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Table 1: The utilized primary and secondary antibodies. 
Method Primary Antibody Dilution Secondary 
Antibody 
DIFS hAPP/ 
Parvalbumin 
Rabbit anti-
parvalbumin 
1:4000 Donkey anti-rabbit 
(Cy2-conjugated) 
DIFS hAPP / 
Calretinin 
Rabbit anti-
calretinin 
1:1000 Donkey anti-rabbit 
(Cy2-conjugated) 
DIFS hAPP / 
Calbindin 
Rabbit anti-
calbindin 
1:1000 Donkey anti-rabbit 
(Cy2-conjugated) 
DIFS hAPP / 
Somatostatin 
Goat anti-
Somatostatin 
 
1:200 Donkey anti-goat 
(Cy2-conjugated) 
 
3.1 Double immunofluorescence staining 
DIFS combines the two benefits of saving time, due to concurrent targeting of two 
antigens on one tissue, and the possibility of finding colocalising compounds, which 
could elucidate possible collaboration of these compounds in molecular mechanisms that 
may be crucial for the development or prevention of AD. DIFS utilizes a primary and a 
secondary antibody-cocktail. The secondary antibody-cocktail used in the following 
stains included antibodies conjugated to the cyanine fluorophores Cyanine (Cy2) and 
Indocarbocyanine (Cy3), which have excitation and emission peaks at different 
wavelengths that are listed in table 2. A signal-enhancing antibody-cocktail can be added 
after incubation with the secondary antibodies. Signal-enhancers in form of another Cy3-
/Cy2 -conjugated secondary antibody and Streptavidin-Cy3 were tested on the tissue and 
resulted in a very intense background signal, which led to abolishment of the signal-
enhancing step in the protocol. Additional testing of the cyanides was done, to determine 
the best fluorescent marker for hAPP. The tissue marked with Cy3 had a much more 
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intense fluorescent hAPP -stain, thus this cyanide was chosen to be utilized in every 
following double immunofluorescence method for marking hAPP. Consequently, the 
antibodies against CaBPs were conjugated with Cy2. 
Every primary antibody-cocktail was diluted in TBS, 5% donkey-normal serum and 0,2% 
Triton X-100 and every secondary antibody-cocktail in TBS and 2% bovine serum 
albumin. After both antibody-incubations, every stained tissue was rinsed thoroughly 
with TBS, placed on protein glycerol–coated microscopic slides and mounted with 
Entellan® for proper examination of the results. Entellan® is a water-free mounting 
medium, containing toluene.62 
 
Table 2: The cyanine fluorophores used in the methods and their excitation and emission peak 
wavelengths. 
Cyanine 
fluorophore 
Acronym Excitation peak 
(nm) 
Emission peak 
(nm) 
Cyanine Cy2 492 510 
Indocarbocyanine Cy3 550 570 
The given values are only approximate and differ depending on the spectrofluorometer that is used. 
 
3.1.1 Pre-treatment of tissue 
The preserved tissue was treated with PBS (0,1 M, pH 7,4) for 10 minutes, following a 
5-minute rinse in TBS (0,1 M, pH 7,4). After the rinse, Methanol (60%) was applied for 
60 minutes. After stabilization, the tissue was incubated with TBS, 5% donkey-normal 
serum and 0,3% Triton X-100 for 45 minutes, to prevent unspecific binding. 
3.1.2 DIFS of hAPP and parvalbumin 
Since parvalbumin is found in 40% of all interneurons, parvalbumin antibodies detect the 
majority of these cells.63 The primary antibody-cocktail was applied to the pre-treated 
tissue, containing rat anti-human APP (1:2) and rabbit anti-parvalbumin (1:2000) and 
                                                 
62 “Entellan® 107960” 
63 Jorge J. Palop and Lennart Mucke: “Network abnormalities and interneuron dysfunction in Alzheimer 
disease” 
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incubated over night at 4°C. The next day, a secondary antibody-cocktail was incubated 
with the tissue for 60 minutes, targeting the primary antibodies. The cocktail contained 
Cy3 -conjugated donkey anti-rat (1:100) and Cy2 -conjugated donkey anti-rabbit (1:100). 
3.1.3 DIFS of hAPP and calretinin 
CR regulates other GABAergic inhibitory interneurons. Although it is one of the least 
abundant CaBPs in the brain, it could disclose CR -specific interneurons.64 The tissue was 
treated with rabbit anti-calretinin (1:1000) and rat anti-human APP (1:2) and incubated 
over night at 4°C. After the incubation, Cy3 -conjugated donkey anti-rat (1:100) and Cy2 
-conjugated donkey anti-rabbit (1:100) covered the tissue for an hour. 
3.1.4 DIFS of hAPP and calbindin 
Calbindin prevents flooding of neurons with glutamate, released from damaged neurons 
and is therefore an important marker for AD -research.65 Rabbit anti-calbindin-D28k 
(1:2000; the dilution of 1:1000 resulted in a high background signal) and rat anti-human 
APP (1:2) were applied to the tissue, which was then incubated over night at 4°C. The 
next day, the tissue was incubated with Cy3 -conjugated donkey anti-rat (1:100) and Cy2 
-conjugated donkey anti-rabbit (1:100) for one hour. 
 
3.1.5 DIFS of hAPP and somatostatin 
Immunohistochemical stains of transgenic mouse-hippocampi with AD -pathology have 
shown a significantly reduced number of SST -positive interneurons compared to 
wildtype mouse tissue. Therefore, it was decided to use antibodies against SST, in order 
to examine the used tissue for this possible AD -pathologic characteristic.66 The primary 
antibody-cocktail for this method contained rat anti-human APP (1:2) and goat anti-SST 
(1:100, the given dilution of 1:200 resulted in a not sufficiently stained tissue) and was 
incubated with the tissue over night at 4°C. The secondary antibody-cocktail consisted of 
Cy3 -conjugated donkey anti-rat (1:100) and Cy2 -conjugated donkey anti-goat (1:100).  
                                                 
64 David Baglietto-Vargas et al.: “Calretinin interneurons are early targets of extracellular amyloid-beta 
pathology in PS1/AbetaPP Alzheimer mice hippocampus” 
65 Andressen C. et al: “Calcium-binding proteins: selective markers of nerve cells.” 
66 Yadong Huang and Lennart Mucke: “Alzheimer mechanisms and therapeutic strategies” 
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4 Results 
The hippocampi of each fluorescently stained wildtype (WT) and transgenic (TG) tissue 
were photographed with BIOREVO BZ-9000, to gather enough data for a statistical 
evaluation of the immunohistochemical labellings. According to the cyanine-conjugated 
secondary antibody used in the individual labelling, a specific filter was used to 
photograph the hippocampi. Antibodies conjugated to Cyanine (Cy2), emit light in the 
green region of the visible spectrum, whereas those conjugated to Indocarbocyanine 
(Cy3) emit red light.  
For the evaluation of possible colocalizations, the Keyence Corporation BZ-II Analyzer 
(version 2.2) was used to create an overlay of a green-fluorescent CaBP- or SST -marked 
transgenic tissue with the according red-fluorescent hAPP -labelling of the same tissue. 
With the same program, CaBP-, SST -positive and hAPP -expressing interneurons were 
counted and the number of interneurons containing both hAPP and a CaBP or SST was 
determined. The chapter 9 ‘appendices’ contains tables with all interneuron -numbers 
counted, which were analysed in the Results section. 
Unfortunately, the number of interneurons located in the stratum pyramidale and stratum 
granulosum could only be estimated, because of the high cell density presented in these 
layers.  
Table 3 contains necessary information about the transgenic mice of the type Tg2576, 
whose tissue was photographed.  
Table 3: Age and ID of transgenic mice, whose tissue is displayed in the figures. 
Method Figure Identifier Age 
hAPP/ Parvalbumin 8,9 Tg: 
#242 
Wt: 
#545 
Tg: 
3 months 
Wt: 
3 months 
hAPP/ Calretinin 10,11 Tg: Tg: 
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#242 
Wt: 
#545 
3 months 
Wt: 
3 months 
hAPP/ Calbindin 12,13 Tg: 
#242 
Wt: 
#544 
Tg: 
3 months 
Wt: 
3 months 
hAPP/ SST 15,16 Tg: 
#541 
Wt: 
#545 
Tg: 
3 months 
Wt: 
3 months 
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4.1  DIFS of hAPP and parvalbumin 
The PV -stain of transgenic (TG) and wildtype (WT) -mice showed clear differences 
regarding the cell types of interneurons, which can be seen in figure 8. TG outnumbered 
the stained interneurons in the WT -tissue (for quantification see chapter 9.1, table 4). 
The WT -tissue showed the most PV -immunoreactivity in the stratum pyramidale, 
whereas the TG -mouse had the highest PV -occurrence in the subiculum. The highest 
hAPP -numbers were discovered in the stratum oriens. The cell density in the pyramidal 
layer, a part of which is shown in figure 8, affected the hAPP- and CaBP-/SST -count 
negatively in almost all stains regarding the identification of smaller and weakly stained 
neurons. Thus, the cell numbers in the pyramidal cell layers can only be estimated and 
are likely much higher than stated. 
 
Figure 8: Overview of PV -positive interneurons (green) and of hAPP -expressing interneurons (red) in wildtype and 
transgenic mouse hippocampus (top row). The bottom row shows higher magnification images of stained interneurons in 
the stratum oriens. 
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Figure 9: The upper left picture shows a basket cell in the stratum granulosum of a TG -mouse 
immunoreactive for parvalbumin (PV). The upper right picture contains a chandelier cell, found in the 
stratum oriens of a TG mouse. The pictures underneath are general depictions of a basket cell (left; 
source: http://www.gregadunn.com/wp-content/uploads/2014/02/Basket-Cells.jpg; edited by: Emira 
Shehabi) and a chandelier cell (right; source: http://neuronbank.org/wiki/images/8/8e/Mine.jpg, edited 
by: Emira Shehabi). Status: 07.08.2017. 
 
In the stains, typically formed PV -positive interneurons were detected. A basket cell in 
the stratum granulosum in a TG mouse hippocampus with visible axons vertically 
projecting into the stratum moleculare, is demonstrated on the left picture of figure 9 
(Top, arrow). A second type of typical PV -interneuron is the chandelier cell, which was 
found in the stratum oriens of a TG mouse hippocampus, projecting into the stratum 
pyramidale and stratum oriens. Both interneurons had a very clear form, visible axons 
and synaptic endings, which can be compared with the generalized pictures of such 
interneuron shapes in figure 9. 
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4.2 DIFS of hAPP and calretinin 
 
The CR -labelling demonstrated a similar outcome to the PV -immunohistochemistry 
regarding the number of marked interneurons, which was higher in TG (for quantification 
see chapter 9.1, table 5). As demonstrated in figure 10 (bottom row), the axons of the 
interneurons in the TG -tissue are more visible than in the WT mouse hippocampus. 
Again, the WT -tissue exhibited most marked interneurons in the stratum pyramidale and 
the TG -tissue in the subiculum. The highest hAPP -numbers could also be found in the 
stratum oriens. 
 
 
 
Figure 10: Overview of CR -positive interneurons (green) and of hAPP -expressing interneurons (red) in wildtype and 
transgenic mouse. The bottom row shows higher magnification images of marked interneurons in the stratum oriens, 
stratum pyramidale and stratum radiatum. 
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Figure 11: The upper pictures show CR -typical interneurons in TG mouse hippocampi. From left to 
right: bitufted cell in the stratum radiatum, horizontal neuron in subiculum and basket-like cell in 
subiculum. The pictures underneath display a generalized picture of a bitufted (left; source: 
http://retina.umh.es/Webvision/imageswv/BasicCells.jpg; edited by: Emira Shehabi) and bipolar 
interneuron (right; source: http://media.buzzle.com/media/images-en/illustrations/human-biology/900-
42870382-bipolar-neuron.jpg; edited by: Emira Shehabi). Status: 07.08.2017. 
 
One of the four CR -typical interneuron-types was not detected in the brain tissue 
analysed, which is the double bouquet cell. Finding certain interneurons in the tissue was 
not always an easy task, because of the different tissue qualities and differential 
descriptions of these interneurons, stated from various research groups. Although it is not 
certain, the CR -labelling in a tissue slice appears to have marked a bitufted cell in the 
stratum radiatum, whose axons are projecting into the stratum pyramidale and stratum 
lacunosum moleculare and can be seen on figure 11. Another, at first bipolar-appearing 
interneuron was found in the subiculum of a stain without any visible arborizations of the 
axon, which led to the assumption of it being a horizontal interneuron. An arborizing 
basket-like interneuron could also be found in the subiculum. 
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4.3 DIFS of hAPP and calbindin 
In the TG -mouse tissue, the interneurons of the pyramidal cell layer demonstrated larger 
axonal projections into the stratum radiatum than in WT, which is shown in figure 12. 
These axonal projections of pyramidal interneurons were a characteristic of the CB -stain, 
represented in every marked tissue. The total number of CB -positive interneurons was 
surprisingly much higher in TG (for quantification see chapter 9.1, table 6). The highest 
interneuron-numbers were found in the stratum oriens in the WT and the stratum 
pyramidale of the TG -tissue. The highest hAPP -occurrence was seen in the stratum 
pyramidale.  
 
 
 
Figure 12: Overview of CB -positive interneurons (green) and of hAPP -expressing interneurons (red) in wildtype and 
transgenic mouse. The bottom row shows higher magnification images of CB -stained interneurons in the stratum oriens, 
stratum pyramidale and stratum radiatum. 
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Figure 13: A high number of typically formed, CB -expressing interneurons could be found in both TG- 
(bottom row) and WT -tissue (top row). Top row: 1. Double bouquet cell in subiculum. 2. Chandelier cell 
in subiculum. 3. Horizontal cell in stratum oriens. Bottom row: 4. Chandelier-looking cell in subiculum. 
5.Bitufted-looking cell in stratum radiatum. 
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Figure 14: Depiction of a double bouquet cell. Source: http://www.genesis-
sim.org/GENESIS/Tutorials/genesis-intro/tutfigs/cortical_cells4.gif; edited by: Emira Shehabi. Status: 
14.08.2017. 
 
Calbindin is expressed in several types of interneurons, some of which could be 
discovered here, as seen on figure 13. In picture 5 of figure 13, a possibly bitufted 
interneuron was detected in the stratum radiatum of a Tg2576 hippocampus. Because of 
the several axons, it could also represent a chandelier cell. The same case is depicted in 
picture 4, showing either a bitufted or chandelier cell (because of an edgy appearance of 
the cell body) in the subiculum of a TG -tissue. A double bouquet cell was found in the 
subiculum of a WT -stain (picture 1) and is characterized by several arborizations on the 
ends of its axons, which are weakly stained. It can be compared with the generalized 
picture of a double bouquet cell in figure 14. A typical chandelier cell in the subiculum 
of a WT -stain can be viewed in picture 2. It owns a clear form with an edgy cell body 
and axons arranged in a triangular, chandelier-like way with several axons projecting 
horizontally into the stratum radiatum and only one axon vertically into the stratum 
pyramidale. Lastly, a horizontal interneuron or double bouquet cell can be seen in picture 
3, which is located in the stratum oriens of a calbindin labelling. Because of visible axonal 
arborizations and a similarity to the interneuron in picture 1, it is more likely to be a 
double bouquet cell. The interneuron types that were not found were the bitufted and the 
basket cell, the latter of which is typically expressed in the pyramidal layer, which is very 
fluorescent in the stain and thus complicated the search. Noticeable were the clear forms 
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of interneurons in the WT -tissue, which affected the identification of CB -typical 
interneurons very positively.   
 
4.4 DIFS of hAPP and somatostatin 
 
The SST -labelling showed a decrease in compound-levels in the transgenic animal (for 
quantification see chapter 9.1, table table 7). As seen on figure 15 (bottom row), the 
interneurons of TG and WT -tissue exhibited big cell nuclei. The most interneurons could 
be found in the stratum oriens of the WT and TG -mouse tissue. The highest hAPP -
numbers were seen in the stratum oriens, closely followed by the subiculum.  
 
Figure 15: Overview of SST -positive interneurons (green) and of hAPP -expressing interneurons (red) in wildtype and 
transgenic mouse. The bottom row shows higher magnification images of interneurons in the DG -area. 
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Figure 16: In the WT -tissue on the left picture, a martinotti-like cell was discovered. On the right 
picture, a basket cell-like interneuron was found in TG -tissue. 
 
A possibly basket-like interneuron with a large cell nucleus could be found in a TG -tissue 
in the stratum radiatum, whereas in the stratum oriens of a WT -stain a martinotti type of 
cell was discovered, with several axons spiking out of its cell body and several 
arborizations of its axons. Both cell types can be seen in figure 16. SST is typically 
expressed in martinotti cells and thus should be included in SST -stains. 
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4.5 Quantitative comparison of CaBP- and SST -positive interneurons in transgenic 
mice and wildtype mice 
 
 
 
Figure 17: A statistical comparison of the number of CaBP- and SST -positive interneurons in TG and 
WT, in hippocampal layers. The numbers are demonstrated in two diagrams, because of very low 
interneuron-numbers in the strata lacunosum moleculare, moleculare, granulosum and the hilus. These 
strata are represented in the second diagram. 
 
The Cy2 -marked interneurons, expressing the CaBPs PV, CR and CB and the 
neuropeptide SST were counted in 8 regions of both hippocampi in the brains of WT and 
TG -mice. Additionally, Cy3 -marked, hAPP -expressing interneurons were counted in 
the hippocampi of TG -mice. Interneurons co-expressing hAPP and CaBPs or the 
neuropeptide SST in the stained tissue were quantified by exact overlaying of the green 
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Cy2- and red Cy3 -labelling of the same tissue. The obtained interneuron-numbers were 
averaged and used for further statistical analyses.  
First, potential differences in the numbers of CaBP- and SST -expressing neurons 
between WT and TG -mouse tissue were analysed. The numbers are presented in two 
diagrams because the interneuron-number in some hippocampal layers was rather low 
and did not fit the y-scale. The statistic evaluation of the counted CaBP- or SST -labelled 
interneurons in all TG and WT -tissues analysed, revealed only for the SST -labelling 
more interneurons in the WT -tissue than in TG hippocampus, with an averaged number 
of 323±42 SST -positive interneurons. Surprisingly, all CaBP -positive interneurons were 
found at higher numbers in the TG mouse hippocampus.  
As demonstrated in figure 17, calbindin was the CaBP expressed at the highest numbers 
out of all CaBPs and neuropeptides. In both WT and TG hippocampus, CB was detected 
in numbers near and over 100, especially in the subiculum (WT: 70±18; TG: 218±12), 
stratum oriens (WT: 194±10; TG: 106±30), stratum pyramidale (WT: 116±72; TG: 
239±136) and stratum radiatum (WT: 93±42; TG: 159±41). CR was especially dominant 
in the stratum pyramidale (89±16) and stratum radiatum (71±7) in WT and in the 
subiculum (69±12) and stratum pyramidale (53±5) in TG. PV only occurred in high 
numbers in the subiculum (107±23) and stratum pyramidale (64±38) in TG and in the 
stratum pyramidale (111±16) and stratum oriens (67±8) in WT. SST had a high 
occurrence in the stratum oriens (WT: 125±14; TG: 128±29) and the hilus (WT: 22±3; 
TG: 29±12) in both mouse genotypes, the latter of which is known to contain many 
interneurons with SST -like immunoreactivity. In addition, it was found that the three 
CaBPs were the most prominent in the stratum pyramidale and the neuropeptide SST had 
its strongest occurrence in the stratum oriens in both TG and WT. 
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4.6 Comparison of CaBP-, SST- and hAPP -expressing interneuron-numbers in the 
wildtype and transgenic hippocampus 
 
 
Figure 18: Comparison of the numbers of PV -positive neurons in WT and TG mouse hippocampus with 
hAPP -expressing interneurons and colocalization of PV and hAPP. 
 
Second, a comparison of the numbers of CaBP-, SST- and hAPP -expressing interneurons 
in the wildtype and transgenic hippocampus tissue, with an additional comparison of the 
neuronal numbers coexpressing both proteins, was made. 
PV -expressing interneurons were found in the highest quantity in the subiculum of the 
TG -mouse tissue (107±23; all numbers are given in chapter 9.1, table 4) and the stratum 
pyramidale (111±16) of the WT -mouse tissue, whereas almost no PV -labelling was 
found in the stratum lacunosum moleculare, the stratum moleculare, stratum granulosum 
and the hilus for both TG and WT mice. Summing up all hippocampal layers, the 
transgenic tissue contained more PV neurons (249±37) than WT (243±36). The highest 
number of neurons expressing the hAPP transgene was found in stratum oriens (251±102) 
and the subiculum (206±9). The highest number of neurons coexpressing hAPP and PV 
was found in the subiculum (75±14), followed by the stratum pyramidale (44±31). 
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Figure 19: Comparison of the numbers of CR -positive neurons in WT and TG mouse hippocampus with 
hAPP -expressing interneurons and colocalization of CR and hAPP. 
 
Compared to the PV -labelling, there were more CR -immunoreactive neurons in every 
layer of the hippocampus. The highest quantity of CR -positive interneurons was found 
in the subiculum of the TG -tissue (69±12; all numbers are given in chapter 9.1, table 5) 
and the stratum pyramidale (89±16) of the WT. More CR -positive neurons were found 
in the transgenic tissue (317±16) than in the WT -tissue (292±29). The highest hAPP -
occurrence was found in stratum oriens (262±28) and the stratum pyramidale and 
subiculum with an estimated number of 200 each, which is likely much higher due to its 
high cell density. Colocalizations of hAPP and CR were found especially in the hilus 
(19±16) and followed by the stratum pyramidale (16±6).  
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Figure 20: Comparison of the numbers of CB -positive neurons in WT and TG mouse hippocampus with 
hAPP -expressing interneurons and colocalization of CB and hAPP. 
 
The highest numbers of neurons labelled for CaBPs were detected by the CB 
immunohistochemistry with total numbers in the TG stratum pyramidale of 239±136 (all 
numbers are given in chapter 9.1, table 6) and the stratum oriens of WT (194±10). The 
transgenic mice showed a much higher number of CB (579±79) than WT (492±66). The 
highest hAPP -concentration was found in the stratum pyramidale with an estimated 
number of 400 (which is likely much higher) and the subiculum (218±26). CB was found 
to be mostly colocalized with hAPP in the stratum pyramidale (211±115) and stratum 
oriens (59±19), the first of which indicates the highest colocalization-number out of all 
CaBPs and neuropeptides tested in this project.  
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Figure 21: Comparison of the numbers of SST -positive neurons in WT and TG mouse hippocampus with 
hAPP -expressing interneurons and colocalization of SST and hAPP. 
 
In comparison to the CaBPs, the neuropeptide SST was expressed by fewer neurons, 
except in the stratum oriens, where relatively high numbers of neurons positive for SST 
were found. Stratum lacunosum moleculare, stratum moleculare and the stratum 
granulosum showed almost no SST -immunoreactivity. As mentioned, the highest 
occurrence of SST was found in the stratum oriens of TG (128±29) and WT (125±14) 
mice (all numbers are given in chapter 9.1, table 7). More SST -positive neurons were 
discovered in the WT (323±42) than in TG (297±40) and therefore it marked the first and 
only compound in the project that showed less interneurons in TG. The hAPP was found 
to be mostly expressed in stratum oriens (299±40) and the subiculum (291±25). Since 
hAPP and SST were found mostly in stratum oriens and the subiculum, the most 
colocalizations occurred in these layers (stratum oriens: 65±20; subiculum: 27±7).  
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4.7 Ratio of CaBP-, SST- and hAPP -positive interneurons to average hAPP -positive 
interneuron-number of all stains per hippocampal layer 
 
 
Figure 22: This diagram demonstrates the total, average hAPP -numbers per layer in all performed 
stains and the average colocalization-rates of the CaBPs/ SST with hAPP per layer. 
 
Next, the average numbers of interneurons per layer, co-expressing hAPP and CaBPs/ 
SST were compared to the hAPP -numbers that have been averaged for every layer in all 
stains (CB, PV, CR, SST) to examine the colocalization-rates. As previously mentioned, 
the highest numbers of neurons coexpressing CaBPs and hAPP were detected for CB in 
the stratum pyramidale (table 12). In this layer, an average number of 215±118 hAPP -
positive neurons was calculated and 211±115 CB- and hAPP -positive interneurons were 
counted. In the subiculum, PV had the second highest degree of colocalization with hAPP 
of 75±14 PV- and hAPP -positive interneurons and 229±36 hAPP -expressing 
interneurons. In the same layer, CB reached a colocalization-number of 55±4, marking 
CB as the second most colocalizing compound in this layer. The stratum oriens contained 
a very high number of 247±45 hAPP -positive interneurons and 65±20 SST- and hAPP -
expressing interneurons. In the stratum radiatum, CB was again the compound with the 
highest colocalization of 36±26. In the other layers, the number of hAPP -positive 
interneurons was much higher than the colocalization of CaBPs/SST. The strata 
lacunosum moleculare, moleculare, granulosum and the hilus delivered only a low 
number of CaBP-/SST -positive interneurons, but even in the stratum lacunosum 
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moleculare and the stratum moleculare mostly CB, closely after CR, was colocalizing 
with hAPP. 
 
4.8 Comparison of CaBP- or SST- and hAPP -positive interneurons in all layers of 
the hippocampus 
 
 
Figure 23: This statistical evaluation states the percentages of colocalizing CaBPs/ SST with hAPP per 
averaged, total CaBP-/ SST-number in the same hippocampal layer. 
 
The percentage of colocalizing CaBPs/SST to the total CaBP-/SST -count in every layer 
was calculated to reveal how many counted CaBPs/SST were simultaneously colocalized 
with hAPP. In almost every layer, except for the stratum lacunosum moleculare and 
stratum moleculare, over 50% of PV was colocalized with hAPP (all numbers are given 
in chapter 9.4, table 13). The subiculum contained the highest percentage of colocalizing 
PV with 70%. In the strata oriens, pyramidale, lacunosum moleculare and moleculare 
over 50% of CB was found to be colocalizing with hAPP. The stratum pyramidale 
contained 88% and the stratum moleculare 72% of CB. Remarkably, every SST -positive 
interneuron in the stratum lacunosum moleculare was noticed to colocalize with every 
marked hAPP -expressing interneuron. Additionally, 63% of SST was colocalized with 
hAPP in the stratum radiatum. Only in the hilus, CR was found to be the most colocalized 
compound with over 68%.  
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5 Discussion 
The aim of this project was to analyse the cell type-specific coexpression of the hAPP 
transgene by CaBP -expressing interneurons in the hippocampus in the Tg2576 mouse 
model of AD. To address this issue, hippocampal brain sections of three, three-month-old 
hAPP -transgenic (TG) Tg2576 mice and three wildtype (WT) mice were treated with 
antibodies against the CaBPs parvalbumin, calretinin, calbindin and the neuropeptide 
somatostatin. The hAPP -expressing interneurons were marked with antibodies in the 
transgenic tissue concurrently, to calculate absolute numbers and proportions of 
hippocampal interneurons coexpressing hAPP and the respective CaBP or the 
neuropeptide SST.  
The hippocampal layers of WT and TG -tissue with the highest occurrences of CaBPs, 
SST and hAPP found in this project were the stratum oriens, stratum pyramidale and the 
subiculum. In the WT -tissue alone, most interneurons were found in the stratum 
pyramidale of the PV- and CR -labelling and the stratum oriens of the CB- and SST -
stain. The TG -tissue showed the highest numbers of interneurons in the subiculum of the 
PV- and CR -labelling, the stratum pyramidale of the CB -stain and the stratum oriens of 
the SST -labelling. The highest hAPP -numbers of both WT and TG -mice tissue were 
found in the stratum oriens of the PV-, CR- and the SST -labelling, as well as the stratum 
pyramidale of the CB -stained tissue.  
The WT reflects the naturally occurring neuronal numbers in a given brain structure 
without any inserted, possibly neuron-damaging genetic mutation, like the AD -mutation 
in Tg2576 -mice that accumulates AD -like plaques in the brain and leads to reduced 
neuronal numbers in clinical AD. Therefore, it was expected to also find a higher number 
of CaBPs and SST in the murine WT than TG -tissue, which was thought to exhibit much 
less CaBP- and SST -positive interneurons. Surprisingly, the only protein that was found 
in higher numbers in the marked WT -hippocampi was SST. This is the only result of this 
project, that partly correlates with the findings about clinical AD, which report reduced 
neuronal numbers of CaBP- and neuropeptide-expressing interneurons and therefore 
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higher numbers in patients without AD. 67,68,69 Regarding the occurrence in hippocampal 
layers, the labelling showed much higher numbers in the hilus of TG- and WT -
hippocampus than CB and PV and contained high numbers of SST -expressing 
interneurons in the stratum oriens in the TG -tissue and in the stratum pyramidale of the 
WT hippocampal tissue. These strata are generally known to contain the highest density 
of SST neurons, together with the hilus. However, almost no SST -immunoreactivity was 
found in the stratum moleculare and stratum granulosum of the DG, which corresponds 
with the reports of Sloviter et al., that also found a rather rare occurrence of SST in these 
two layers.70 
Inhibitory, GABAergic interneurons have been found to comprise around 11% of the total 
neuron population in the hippocampus.71 Previous studies have described PV -
immunoreactive interneurons to form 32-38% of these GABAergic interneuron-
population in the hippocampus.72 Interestingly, in this project PV appeared to be 
distributed in high quantities only in the stratum pyramidale and oriens in the WT -mice 
and the subiculum and stratum pyramidale in the TG -mice with a total number of 243±36 
in the WT and 249±37 in the TG -mice. However, the numbers of PV -positive 
interneurons in these layers were highly outnumbered by the CB -marked tissue, which 
showed a much higher immunoreactivity in the same layers in both TG- and WT -
labellings.  
                                                 
67 Jean-Pierre et al. Brion: “A subset of calretinin-positive neurons are abnormal in Alzheimer's disease” 
68 Harald Stefanits, Carolin Wesseling and Gabor G. Kovacs: “Loss of Calbindin immunoreactivity in the 
dentate gyrus distinguishes Alzheimer's disease from other neurodegenerative dementias” 
69 “Parvalbumin-immunoreactive neurons in the hippocampal formation of Alzheimer's diseased brain - 
ScienceDirect” 
70 RS. Sloviter and G. Nilaver: “Immunocytochemical localization of GABA-, cholecystokinin-, vasoactive 
intestinal polypeptide-, and somatostatin-like immunoreactivity in the area … - PubMed - NCBI” 
71 Godavarthi S. et al: “Reversal of reduced parvalbumin neurons in hippocampus and amygdala of 
Angelman syndrome model mice by chronic treatment of fluoxetine - Godavarthi - 2014 - Journal of 
Neurochemistry - Wiley Online Library” 
72 Ibid. 
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Previously, CB has been reported to occur in only 10-20% of GABAergic interneurons, 
located in the hippocampus.73 However, in this project CB was found to be the most 
abundantly occurring protein in TG- and WT -mice in almost all layers out of all the 
marked CaBPs and neuropeptides with a total average of 492±66 marked CB -positive 
interneurons in the WT and 579±79 in the TG -mouse. In only 3 of the 8 examined 
hippocampus layers, which were the stratum oriens, stratum radiatum and hilus, the WT 
-mouse had a higher number of CB -positive neurons than the TG -mouse. The obtained 
average hAPP -numbers of the CB -stained tissue slices were the second highest after CR, 
and CB was found to colocalize with hAPP in many more layers in higher numbers than 
the other CaBPs. The reason for the higher number of CB -expressing interneurons in the 
transgenic tissue is unclear, because there are no obvious reasons for this result, such as 
bad quality of WT -tissue and therefore a lower amount of marked CaBPs. Consecutive 
brain sections from the same WT- and TG -tissue were used in all methods to ensure the 
analyses of identical brain structures with comparable neuronal densities. Furthermore, 
mice analysed were of the same age.  
In regard to other studies with CaBPs, the numbers obtained in this project could be the 
result of a weak primary antibody against PV, which can be assumed because of a similar 
problem during the labelling of CB and CR. Since the CB- and CR -labelling resulted in 
very weakly stained tissue, it was decided to perform the same stain with newly ordered 
primary antibodies against CB and CR, which succeeded in binding more CaBPs and 
therefore produced an intense stain of the tissue. Indeed, the new antibody against CR 
and CB marked much more interneurons than the antibody against PV and resulted in the 
highest CaBP -positive interneuron numbers that were obtained in both WT- and TG -
tissue. Although CR -positive interneurons have been reported to only form about 13% 
of all GABAergic interneurons in the hippocampus, the CR -labelling in this project 
marked the second highest CaBP -number in tested WT- and TG -mice.74 The labelling 
of PV didn’t show any weakly stained PV -positive interneurons, but the obtained PV -
numbers were too low, when compared to the numbers of CB- and CR -labelled 
                                                 
73 Ibid. 
74 Dhiraj Maskey et al.: “Changes in the distribution of calbindin D28-k, parvalbumin, and calretinin in the 
hippocampus of the circling mouse” 
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interneurons, since PV should be distributed in higher concentrations among the 
hippocampus. 
Nonetheless, a malfunctioning primary antibody against PV doesn’t explain the high 
colocalization of CB with hAPP, which was observed in this project. The obtained 
colocalization-numbers could indicate a protecting mechanism by CB against A-β, which 
was discovered by Moon et al. The researchers used three-months-old tissue from a 
different transgenic mouse line (5XFAD) with 5 AD -mutations, which was incubated 
with mouse anti-human A-β and antibodies against CaBPs and A-β. The results showed 
no plaques in the regions containing CB -expressing interneurons and let the researchers 
conclude, that CB can hinder A-β -accumulation in interneurons and therefore the 
formation of plaques.75 If these results are applicable to all CB -immunoreactive 
interneurons in transgenic mouse hippocampi and especially the Tg2576 -mouse line, the 
high CaBP- and colocalization-numbers of the CB -labelling in this project could provide 
further evidence for a protecting mechanism by CB against A-β.  
Because of insufficient evidence, it is not exactly known if CaBPs generally have an 
ability to suppress APP -processing and the generation of A-β or if only the accumulation 
into plaques can be prevented.76 The study didn’t mention any analysed colocalizations 
of CB and hAPP, which could have explained if CB can colocalize with a certain level of 
hAPP, concurrently hindering the accumulation of more into plaques. Therefore, it is 
unclear if the CB in this project, that was found to colocalize with hAPP, would have 
hindered the accumulation of more A-β into plaques or if the results of the mentioned 
study are only applicable to the 5XFAD -mouse type and the obtained CB -numbers of 
this project would have reduced with increasing age and initiating A-β deposits in the 
tested transgenic mice.  
 
                                                 
75 Minho Moon et al.: “Intracellular amyloid-β accumulation in calcium-binding protein-deficient neurons 
leads to amyloid-β plaque formation in animal model of Alzheimer's disease” 
76 Ibid. 
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In clinical AD, parvalbumin-, calretinin- and calbindin-levels were proven to decrease 
with higher APP -levels. 77,78,79  Some research has shown, that high APP -concentrations 
can be related with reduced CaBP -numbers in transgenic mice with the hAPP -transgene 
as well, but a number of other studies have stated the opposite and therefore the exact 
molecular relationship between hAPP and CaBPs in transgenic mice is not known.80  
In aged humans and certain animals, A–β has been shown to be affected by Ca2+ -ions 
and concurrently be able to influence the influx of these ions, which has an impact on 
CaBPs. In experiments, “a spectrum of Aβ impact, from complete disintegration of the 
[…] bilayer phase to modest perturbations in bilayer structure and enhanced permeability 
of [Ca2+-] ions” 81 was discovered by Lockhart et al. These disordering effects strengthen 
with deeper embedding of A-β into the membrane and increases the calcium-influx into 
the area, elevating the local concentration of ions by over 25% because of the strong 
binding affinity of calcium towards negatively charged amino acids and thus A-β. Ca2+ -
ions have a minor impact on A-β secondary structure, but a much higher influence on the 
tertiary structure by disrupting several intramolecular long-range interactions in the 
peptide. Increased intra- and extracellular calcium-concentrations in the brain have been 
shown to correlate with decreased CB- and CR -levels, accelerating the growth of A-β -
aggregates and the formation of plaques.82 Because of this evidence, a calcium influx-
reducing compound has been given to moderate and severe AD -patients, which has 
shown to improve cognition.83  
                                                 
77 Jean-Pierre et al. Brion: “A subset of calretinin-positive neurons are abnormal in Alzheimer's disease” 
78 Harald Stefanits, Carolin Wesseling and Gabor G. Kovacs: “Loss of Calbindin immunoreactivity in the 
dentate gyrus distinguishes Alzheimer's disease from other neurodegenerative dementias” 
79 “Parvalbumin-immunoreactive neurons in the hippocampal formation of Alzheimer's diseased brain - 
ScienceDirect” 
80 Ibid. 
81 C. Lockhart and D. Klimov: “Calcium Enhances Binding of Aβ Monomer to DMPC Lipid Bilayer” 
82 Ibid. 
83 American Society for Biochemistry and Molecular Biology: “Acceleration of Amyloid β-Peptide 
Aggregation by Physiological Concentrations of Calcium” 
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Generally, interneurons expressing CaBPs are known to have the ability of buffering 
intracellular calcium in humans and rodents, which otherwise may cause excitotoxicity.84 
Hence, if the function of CaBPs is to buffer Ca2+ -concentrations intracellularly, the 
decreased CB- and CR -levels in the experiment of Lockhart et al. had to be caused by 
abnormally high Ca2+ -levels in the neurons that couldn’t be buffered by the CaBPs, or a 
very high calcium-concentration in the extracellular space, since there is no mentioning 
about the ability of CaBPs to buffer Ca2+ extracellularly.  
Regarding the results in this project, it is possible that the study of Lockhart et al. is not 
applicable to Tg2576 mice and the inserted hAPP -gene in the Tg2576 mouse does not 
react with Ca2+ -ions in the same way as in human AD -patients or other animals with the 
hAPP -transgene, since the CR- and CB -levels were not reduced. It could indicate a 
differential interaction by A-β with membranes and lipid bilayers in the Tg2576 mouse, 
which could have little to no impact on Ca2+ -ions and CaBPs. A study of Kalback et al. 
has indeed found significant chemical and physical differences of A-β -deposits in the 
brains of Tg2576 mice, which could include a different impact of hAPP on Ca2+ -ions.85 
Therefore, if the hAPP -transgene in the Tg2576 -mouse doesn’t increase Ca2+ -
concentrations and CaBPs are rather affected (and decreased) by abnormally increased 
Ca2+ -influx than A-β -levels, the high numbers of CaBPs and colocalizing compounds in 
the TG -tissue of this project are logical. Unfortunately, this would discredit Tg2576 as a 
reliable AD -model, even though insertion of the hAPP -gene into these mice does initiate 
accumulation of A-β into plaques. 
Another possibility for the outcome of this project, is that the initial CaBP -concentration 
was higher in the tested transgenic animals and the developed number of A-β didn’t have 
much effect on CaBP -levels yet, because of the young age of tested mice (3 months). By 
early analysis, the possibility of decreased CaBP -levels with increasing age and A-β -
deposits couldn’t be explored. Various stress factors during the transport and storage of 
the transgenic and wildtype animals could also be reasons for the abnormal CaBP -
concentrations or the lower SST -level in the WT -mice. 
                                                 
84 C. E. Ribak, R. Nitsch and L. Seress: “Proportion of parvalbumin-positive basket cells in the GABAergic 
innervation of pyramidal and granule cells of the rat hippocampal formation” 
85 Kalback W et al.: “APP transgenic mice Tg2576 accumulate Abeta peptides that are distinct from the 
chemically modified and insoluble peptides deposited in Alzheimer's disease senile plaques” 
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In conclusion, the obtained data in this project was rather unexpected, since PV-, CB- and 
CR -levels have all been found to decrease or at least abnormally develop in the brains of 
human AD -patients.86,87,88 If neuronal loss is a major characteristic of clinical AD and 
this and other studies, e.g. by researchers such as Irizzary et al. resulted in ‘little to no 
loss of neurons in Tg2576 mice’89, this transgenic mouse line should be used with caution 
and regard to controversial studies. If the goal is to gather information about clinical AD, 
which can be used for further evaluation, only those transgenic animal models should be 
used, that are known to display typical neuronal changes, as seen in the clinical disease.  
 
 
 
 
 
 
 
 
 
 
 
 
                                                 
86 Jean-Pierre et al. Brion: “A subset of calretinin-positive neurons are abnormal in Alzheimer's disease” 
87 Harald Stefanits, Carolin Wesseling and Gabor G. Kovacs: “Loss of Calbindin immunoreactivity in the 
dentate gyrus distinguishes Alzheimer's disease from other neurodegenerative dementias” 
88 “Parvalbumin-immunoreactive neurons in the hippocampal formation of Alzheimer's diseased brain - 
ScienceDirect” 
89 Jennifer Horgan et al.: “Longitudinal brain corticotropin releasing factor and somatostatin in a transgenic 
mouse (TG2576) model of Alzheimer's disease” 
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6 Outlook 
Because of unexpected data, which was obtained during the statistical evaluation of the 
labellings and gathered evidence of the Tg2576 mouse line being a rather unreliable 
model for clinical AD, it should be considered to use another animal model or transgenic 
mouse line, which is known to show typical symptoms of clinical AD. Besides the mouse 
line, other factors can be changed for a better evaluation and more reliable results. First, 
animals of increasing age groups should be chosen in order to evaluate how hAPP -
concentrations change with increasing age. This kind of statistical data would have 
answered the question, if the stained mouse-tissue was too young to show a decrease in 
CaBPs. Certainly, it is also possible to use older mice with already formed A-β -plaques 
and high A-β -levels, since these mice should show a significant decrease in CaBP -levels, 
according to clinical AD -neuropathology. Because of the higher lipofuscin-number in 
the tissue of older mice, which has the unfortunate property of intensifying the 
background signal of immunohistochemical labellings, this method would complicate 
statistical evaluation. Therefore, it is rather suggested to perform the 
immunohistochemical staining on increasing age groups of 3-, 6- and 8-months-old tissue 
in order to avoid high lipofuscin-levels but still gather enough information on changes of 
hAPP– and CaBP -numbers with increasing age. Another improvement could be provided 
through a counting software, which is able to exactly detect interneurons in hippocampal 
layers, such as the stratum pyramidale and stratum granulosum. As mentioned, these 
layers often contained a high number of stained interneurons which was too high to be 
counted manually or CaBP- and SST -immunoreactive interneurons were not exactly 
distinguishable from other pyramidal or granular neurons, that weren’t marked. The 
obtainment of an exact interneuron-number in these two layers would immensely benefit 
the comparison of CaBP– and especially hAPP -numbers, which were found to be very 
high in the stratum pyramidale. Another problem occurred during the analysis of many 
labellings, because of a too intensely stained stratum pyramidale and, regarding the CB -
labelling, a too fluorescent DG -area. Here, it should be experimented with the utilized 
volume of primary and secondary antibodies to assure a sufficient, but weaker stain. 
Finally, the employed antibodies must function normally, in order to gather comparable 
data. Because of a possibly malfunctioning primary antibody against PV, the obtained 
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data of the labelling was rather surprising when compared to the other CaBPs, for which 
new primary antibodies were ordered shortly before immunohistochemical staining.  
 
Lastly, it should be considered to not only analyse AD on a microscopic level, but also 
focus on the macroscopic aspect -or on the human himself. How does the average person, 
in parts of the world that have high AD -rates, spend his day and what are factors, still 
unknown to the average human that could trigger a neurodegenerative disease? Evidence 
of AD being a primarily vascular disease has been already published back in 1907 by 
Stelzmann et al., who has observed arteriosclerotic changes in post-mortem tissue of AD 
-patients.90 Researchers at the 39th Annual Williamsberg Conference on Heart Disease 
even explained, how easily atherosclerosis is produced experimentally in herbivores “by 
giving them diets containing large quantities of cholesterol (egg yolks) or saturated fat 
(animal fat)”. 91 Such a diet can additionally cause hypoperfusion by increasingly clogged 
arteries in the whole body, which has also been associated with AD.92 Although many 
confusions exist regarding the best diet for humans, an herbivorous or plant-based diet is 
described as very beneficial for humans of every age in many studies. A plant-based diet 
has even been shown to reverse diseases, like diabetes, cancer and vascular 
diseases.93,94,95,96,97 These findings indicate that most of western diseases, including AD, 
can be provoked with an inappropriate diet. Research should therefore set its focus on 
prevention of these diseases by elucidation of known risk factors which are included in 
                                                 
90 R. et al.A Stelzmann: “An English translation of Alzheimer's 1907 paper, "Uber eine eigenartige 
Erkankung der Hirnrinde". - PubMed - NCBI” 
91 Mina M. Benjamin and William C. Roberts: “Facts and principles learned at the 39th Annual 
Williamsburg Conference on Heart Disease” 
92 Benjamin P. Austin et al.: “Effects of hypoperfusion in Alzheimer's disease” 
93 B. et al. Caldwell: “A way to reverse CAD?” 
94 Tai Le, L. et al.: “Beyond Meatless, the Health Effects of Vegan Diets: Findings from the Adventist 
Cohorts” 
95 Mina M. Benjamin and William C. Roberts: “Facts and principles learned at the 39th Annual 
Williamsburg Conference on Heart Disease” 
96 M. et al. Glick-Bauer: “The Health Advantage of a Vegan Diet: Exploring the Gut Microbiota Connection” 
97 American Dietetic Association: “Position of the American Dietetic Association” 
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the daily routine, especially the diet of an average human, living in parts of the world that 
are highly affected by AD and co.  
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9 Appendices 
9.1 Quantitative comparison of CaBP- and SST-positive interneurons in transgenic 
mice and wildtype mice 
 
Table 4: Quantitative comparison of PV-positive interneurons in transgenic mice and wildtype mice 
PV Subiculum 
St. 
oriens 
St. 
pyramidale 
St. 
radiatum 
St. 
lac/mol 
St. 
mol 
St. 
granulosum Hilus 
wt 36 67,33 110,83 15,83 0,17 1,67 6,83 4 
tg 107 56,83 64,33 10,67 0 1,17 6,17 3,17 
 
Table 5: Quantitative comparison of CR-positive interneurons in transgenic mice and wildtype 
mice 
CR Subiculum 
St. 
oriens 
St. 
pyramidale 
St. 
radiatum 
St. 
lac/mol 
St. 
mol 
St. 
granulosum Hilus 
wt 32,33 47,67 89 70,83 21,5 4,83 2,17 24 
tg 68,67 37,17 53,17 41,83 20,17 20,33 46,67 28,5 
 
Table 6: Quantitative comparison of CB-positive interneurons in transgenic mice and wildtype 
mice 
 
Table 7: Quantitative comparison of SST-positive interneurons in transgenic mice and wildtype 
mice 
SST Subiculum 
St. 
oriens 
St. 
pyramidale 
St. 
radiatum 
St. 
lac/mol 
St. 
mol. 
St. 
granulosum Hilus 
wt 40,33 125,33 77,67 56,17 0 0 1,67 22,17 
tg 55,5 128,33 52,33 30,67 0,33 0,17 0,5 29 
 
 
 
 
CB Subiculum 
St. 
oriens 
St. 
pyramidale 
St. 
radiatum 
St. 
lac/mol 
St. 
mol. 
St. 
granulosum Hilus 
wt 70,17 194 115,67 93,33 10,33 5,67 0 2,33 
tg 127 106 239 85,67 11,67 7,17 0,5 1,83 
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9.2 Total number of marked interneurons in the hippocampus 
 
Table 8: Total number of marked PV-positive interneurons in the hippocampus 
PV Subiculum 
St. 
oriens 
St. 
pyramidale 
St. 
radiatum 
St. 
lac/mol 
St. 
mol. 
St. 
granulosum Hilus 
wt 36 67,33 110,83 15,83 0,17 1,67 6,83 4 
tg 107 56,83 64,33 10,67 0 1,67 6,17 3,17 
hAPP 206,33 250,83 70,17 144,17 73,17 81,17 0 72,5 
Coloc. 75,33 35 43,83 6,5 0 0,83 3,17 2 
 
Table 9: Total number of marked CR-positive interneurons in the hippocampus 
CR Subiculum 
St. 
oriens 
St. 
pyramidale 
St. 
radiatum 
St. 
lac/mol 
St. 
mol. 
St. 
granulosum Hilus 
wt 32,33 47,67 89 70,83 21,5 4,83 2,17 24 
tg 68,67 37,17 53,17 41,83 20,17 20,33 46,67 28,5 
hAPP 200 261,67 200 164,33 114,17 135,83 0 105,7 
Coloc 14,33 11,83 15,5 8 6,17 5,33 14,5 19,33 
 
Table 10: Total number of marked CB-positive interneurons in the hippocampus 
CB Subiculum 
St. 
oriens 
St. 
pyramidale 
St. 
radiatum 
St. 
lac/mol 
St. 
mol. 
St. 
granulosum Hilus 
wt 70,17 194 115,67 93,33 10,33 5,67 0 2,33 
tg 127 106 239 85,67 11,67 7,17 0,5 1,83 
hAPP 218,33 176 400 159,33 57 69 0 69,67 
Coloc 54,83 58,83 210,5 35,5 6 5,17 0 0,67 
 
Table 11: Total number of marked SST-positive interneurons in the hippocampus 
SST Subiculum 
St. 
oriens 
St. 
pyramidale 
St. 
radiatum 
St. 
lac/mol 
St. 
mol. 
St. 
granulosum Hilus 
wt 40,33 125,33 77,67 56,17 0 0 1,17 22,17 
tg 55,5 128,33 52,33 30,67 0,33 0,17 0,5 29 
hAPP 290,83 299,33 191,5 209,33 77,67 89 0 87,17 
Coloc 26,83 65 13,67 19,33 0,33 0,17 0 16,67 
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9.3 Ratio of CaBP-, SST- and hAPP- positive interneurons to average hAPP-positive 
interneuron-number of all stains per hippocampus-layer 
 
Table 12: Ratio of CaBP-, SST- and hAPP -positive interneurons to average hAPP-positive 
interneuron-number of all stains per hippocampus-layer 
 
Subiculum 
St. 
oriens 
St. 
pyramidale 
St. 
radiatum 
St. 
lac/mol 
St. 
mol. 
St. 
granulosum Hilus 
hAPP 
(total) 228,87 246,96 165,42 169,29 80,5 93,75 0 83,75 
PV 75,33 35 43,83 6,5 0 0,83 3,17 2 
CR 14,33 11,83 15,5 8 6,17 5,33 14,5 19,33 
CB 54,83 58,83 210,5 35,5 6 5,17 0 0,67 
SST 26,83 65 13,67 19,33 0,33 0,17 0 16,67 
 
9.4 Ratio of CaBP- and SST-positive and CaBP-, SST- and hAPP-positive 
interneurons in the hippocampus 
 
Table 13: Ratio of CaBP- and SST -positive and CaBP-, SST- and hAPP-positive interneurons in 
the hippocampus 
 
Subiculum 
St. 
oriens 
St. 
pyramidale 
St. 
radiatum 
St. 
lac/mol St. mol. 
St. 
granulosum Hilus 
PV 70,40% 61,59% 68,13% 60,92% 0,00% 49,70% 51,38% 63,06% 
CR 11,28% 31,83% 29,15% 19,13% 30,59% 26,22% 31,07% 67,82% 
CB 43,17% 55,50% 88,08% 41,44% 51,41% 72,11% 0,00% 36,61% 
SST 48,34% 50,65% 26,12% 63,03% 100,00% 100,00% 0,00% 57,48% 
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